Skip to main content
. Author manuscript; available in PMC: 2014 Jul 28.
Published in final edited form as: Cancer Lett. 2013 Mar 6;335(2):361–371. doi: 10.1016/j.canlet.2013.02.058

Table 1.

Summary of cell and tissue specimen analyses

1. Cell line Identification Source Experimental
procedure
Figure
hOPC Human Oligodendrocyte Precursor ScienCell Inc. (Carlsbad, CA) RNA analysis, Western blotting, Immunoprecipitation Figures 1 through 3
HOG Derived from Oligodendroglioma WHO grade II Dr. Glyn Dawson (University of Chicago) RNA analysis, Apoptosis and growth assays, Western blotting, Flow cytometry, Inhibitor treatments, Immunoprecipitation, Retroviral transduction, Immunofluorescence Figures 1 through 5
SJOA1 Derived from Oligodendroglioma WHO grade II Dr. Suzanne Baker (St. Jude Children’s Research Hospital) Western blotting Figure 3
BT54 Derived from Anaplastic Oligodendroglioma WHO grade III Dr. Samuel Weiss (University of Calgary) Western blotting Figure 3
BT88 Derived from Anaplastic Oligodendroglioma WHO grade III Dr. Samuel Weiss (University of Calgary) Western blotting Figure 3
U87 Derived from Human Glioblastoma ATCC Inc. (Manassas, VA) Western blotting, Immunoprecipitation Figure 3
II. Tissue Identification Source Experimental
procedure
Figure
#1 Oligodendroglioma WHO grade II 48 yo white male, donated by Dr. Harald Sontheimer, (University of Alabama). Western blotting Figure 3
#2 Oligodendroglioma WHO grade II 43 yo white female, donated by Dr. Harald Sontheimer, (University of Alabama). Western blotting Figure 3
#3 Oligodendroglioma WHO grade II 65 yo white female, donated by Dr. Harald Sontheimer, (University of Alabama). Western blotting Figure 3
#4 Oligodendroglioma WHO grade II 40 yo white male, donated by Dr. Harald Sontheimer, (University of Alabama). Western blotting Figure 3